首页> 外国专利> 2-(5-TETRAZOLYL AND 5-TETRAZOLYL CARBOXAMIDO) BENZO (AND NAPHTHO) THIOPHENE AND BENZO (AND NAPHTHO) FURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS

2-(5-TETRAZOLYL AND 5-TETRAZOLYL CARBOXAMIDO) BENZO (AND NAPHTHO) THIOPHENE AND BENZO (AND NAPHTHO) FURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS

机译:2-(5-四唑基和5-四唑基羧酰胺基)苯并(萘)噻吩和苯并(萘)呋喃衍生物和药物成分

摘要

There is disclosed a compound having the following general formula (I) CHEM or a pharmaceutically acceptable salt thereof, wherein: R1, R4, and R5 are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, a hydroxy, an aryl, a nitro group, an amino group, a substituted amino group, a mercapto radical, an alkylthio radical having from one to four carbon atoms, an alkylsulphinyl radical having from one to four carbon atoms, an alkylsulphonyl radical having from one to four carbon atoms, an arylthio radical, an arylsulphinyl radical, an arylsulphony radical or a halogen, R1 being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring; R2 is an alkoxy having from one to twelve carbon atoms, an arylmethoxy, an amino group, a substituted amino group., a mercapto group, an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, an arylthio, an arylsulphinyl, or an arylsulphonyl; and R3 is A or B CHEM X is oxygen or S(O)q wherein q is zero, one, or two. Also disclosed is a process for preparing the compounds, compositions comprising the compounds and pharmaceutical uses of the compounds. The novel benzothiophene and benzofuran derivatives have antiallergic activity. The disclosure describes the use of derivatives for prevention of the release of mediators including histamine and leukotrienes from basophils and mast cells, and prevent respiratory burst in neutrophils providing activity useful in cardiovascular disorders as well as in antiinflammatory, psoriasis, and antimigraine treatment.
机译:公开了具有以下通式(I)的化合物或其药学上可接受的盐,其中:R 1,R 4和R 5各自独立地为H,具有1至12个碳原子,1至12个碳原子的烷氧基,羟基,芳基,硝基,氨基,取代的氨基,巯基,具有1至4个碳原子的烷硫基碳原子数为1至4的烷基亚磺酰基基团,碳原子数为1至4的烷基磺酰基基团,芳硫基,芳基亚磺酰基基团,芳基磺酰基或卤素,R 1进一步选自连接的亚甲二氧基基团。苯环的相邻碳原子; R 2是具有1至12个碳原子的烷氧基,芳基甲氧基,氨基,取代的氨基,巯基,具有1至4个碳原子的烷硫基,具有1至4个碳原子的烷基亚磺酰基。原子,具有1-4个碳原子的烷基磺酰基,芳硫基,芳基亚磺酰基或芳基磺酰基; R 3是A或B。X是氧或S(O)q,其中q是0、1或2。还公开了制备化合物的方法,包含该化合物的组合物以及该化合物的药物用途。新的苯并噻吩和苯并呋喃衍生物具有抗过敏活性。本公开内容描述了衍生物用于预防包括嗜碱性粒细胞和肥大细胞的组胺和白三烯在内的介体的释放,并防止嗜中性粒细胞呼吸爆发的作用,提供可用于心血管疾病以及抗炎,牛皮癣和抗偏头痛治疗的活性。

著录项

  • 公开/公告号NZ214479A

    专利类型

  • 公开/公告日1989-08-29

    原文格式PDF

  • 申请/专利权人 WARNER-LAMBERT CO;

    申请/专利号NZ19850214479

  • 申请日1985-12-09

  • 分类号C07D409/04;C07D409/12;C07D405/04;C07D405/12;A61K31/41;C07D333/70;C07D307/85;C07D307/86;C07D307/92;

  • 国家 NZ

  • 入库时间 2022-08-22 06:38:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号